HAIFA, Israel and MIAMI, Nov. 7, 2022 /PRNewswire/ — Insightec, a global healthcare company dedicated to using acoustic energy to transform patient care, today announced the publication of the largest prospective, long-term follow-up study of unilateral MRI-guided focused ultrasound (MRgFUS) thalamotomy for essential tremor to date.
SAN MATEO, Calif.–(BUSINESS WIRE)–Cala, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced that the Centers for Medicare & Medicaid Services (CMS) has set a payment determination and benefit category for the existing unique Healthcare Common Procedure Coding System (HCPCS) code K1018 for Cala TAPS therapy, initially put […]
Cala Health recently published a post-market surveillance study that demonstrates the long-term efficacy of its wrist-based wearable for people with essential tremor, finding that the device reduced patients’ tremor power by 71%. The Burlingame, California-based company was founded in 2014 as a Stanford University spinout. It makes a wrist-based wearable that uses electrical stimulation to temporarily relieve tremor symptoms.
The International Essential Tremor Foundation will bring together experts, scientists, patients, and family members for a day of learning about essential tremor. Lenexa, Kansas – The first ever Essential Tremor Virtual Education Conference will take place Saturday, October, 29, 2022, from 9 AM to 1 PM (CST). Hosted by the International Essential Tremor Foundation (IETF), […]
SAN MATEO, Calif., May 18, 2022–(BUSINESS WIRE)–Cala Health, the bioelectronic medicine leader setting a new standard of patient care for chronic disease, today announced new clinical research presented at ISPOR 2022. The study, titled “Co-Morbidities and Mechanistic Similarities of Essential Tremor and Parkinson’s Disease and Resulting Diagnostic Challenges,” analyzed comorbidities among patients diagnosed with essential tremor and […]
BOSTON, May 09, 2022 (GLOBE NEWSWIRE) — Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today provided a corporate update, including a video highlighting recent business and pipeline progress, and reported financial results for the first quarter […]
Boston Scientific (NYSE:BSX) today announced it received FDA approval for its Vercise Neural Navigator with StimView XT. The Marlborough, Massachusetts–based company designed its latest image-guided programming software in collaboration with Brainlab AG. It enables clinicians in real-time to visualize lead placement and stimulation modeling of the brain anatomy of patients with Parkinson’s disease or essential tremor.
Researchers in China developed and evaluated machine learning algorithms to better identify and classify Parkinsonian and essential tremors for diagnosis. The findings, published in Frontiers in Neuroscience, offer a reference for the intelligent diagnosis of Parkinson disease (PD) and “show promise for use in wearable tremor suppression devices,” authors wrote.
IRVINE, Calif., March 15, 2022 /PRNewswire/ — Allevion Therapeutics announced today that the Medical and Scientific Advisory Board (SAB) is expanding to include three new members — Rajesh Pahwa, M.D., Stuart H. Isaacson, M.D., and Patrick McCartney. The expansion of the board coincides with the successful completion of an initial pilot clinical study.
BURLINGAME, CA — March 1, 2022 — Cala Health, the bioelectronic medicine leader setting a newstandard of patient care for chronic disease, closed 2021 with significant reimbursement accomplishments for patients. New coding and coverage by commercial and government payors makes it easier for physicians to prescribe and patients to afford Cala Health’s clinically proven treatment […]